BP
CELG

Banyan Partners’s Celgene Corp CELG Stock Holding History

Banyan Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$11.2M Sell
117,836
-4,256
-3% -$384K 0.95% 25
2014
Q2 		$10.5M Sell
122,092
-34,792
-22% -$2.65M 0.89% 31
2014
Q1 		$11M Sell
156,884
-56,242
-26% -$4.45M 0.94% 25
2013
Q4 		$18M Buy
213,126
+50,354
+31% +$3.98M 1.26% 10
2013
Q3 		$12.5M Buy
162,772
+35,980
+28% +$2.52M 1.11% 14
2013
Q2 		$7.42M Buy
+126,792
New +$7.63M 1.46% 18

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Banyan Partners's CELG Position: Q3 2014 in Review

Banyan Partners reduced its Celgene Corp (CELG) stake by 3.5% in Q3 2014, selling an estimated $384K and leaving 117,836 shares worth $11.2M. The position accounts for 0.95% of the portfolio, ranked #25.

Banyan Partners first reported a position in CELG in Q2 2013 and has held it in 6 quarters since. The position peaked at $18M in Q4 2013. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • Banyan Partners held 117,836 shares of Celgene Corp worth $11.2M as of Q3 2014.
  • Banyan Partners sold 4,256 Celgene Corp shares in Q3 2014, an estimated $384K.
  • Celgene Corp made up 0.95% of Banyan Partners's portfolio in Q3 2014, its #25 holding.
  • Banyan Partners first reported a position in Celgene Corp in Q2 2013 and has held it in 6 quarters since.
  • Banyan Partners's Celgene Corp position peaked at $18M in Q4 2013.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.